Related Experiment Video

Updated: Jun 16, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Management of essential hypertension

Giuseppe Mancia1, Guido Grassi

  • 1Clinica Medica, Dipartimento di Medicina Clinica e Prevenzione, Università Milano, Milan, Italy. giuseppe.mancia@unimib.it

British Medical Bulletin
|February 11, 2010
PubMed

Insights

Hypertension (HT) is a major cardiovascular risk, but blood pressure (BP) lowering treatments effectively reduce CV events and end-organ damage. Further research is needed for optimal BP control and enhanced cardiovascular protection.

Area of Science:

  • Cardiology
  • Hypertension Management
  • Cardiovascular Risk Reduction

Background:

  • Hypertension (HT) is a significant cardiovascular (CV) risk factor.
  • Elevated blood pressure (BP) directly correlates with increased CV events.
  • HT contributes to end-organ damage, including left ventricular hypertrophy and renal damage.

Purpose of the Study:

  • To review the established benefits of BP-lowering interventions.
  • To identify current unmet goals and unanswered questions in antihypertensive drug treatment.
  • To discuss strategies for optimizing cardiovascular protection in hypertensive patients.

Main Methods:

  • Literature review of epidemiological studies on hypertension and cardiovascular events.
  • Analysis of the effects of antihypertensive drug treatment on CV morbidity, mortality, and end-organ damage.
  • Discussion of current controversies and future directions in hypertension management.

Main Results:

  • BP-lowering interventions significantly reduce CV morbidity and mortality.
  • Treatment can lead to regression or delayed progression of HT-related end-organ damage.
  • Key areas of ongoing debate include target BP values, treatment thresholds, and optimal therapeutic strategies for CV protection.

Conclusions:

  • Antihypertensive treatment has yielded successful outcomes in reducing cardiovascular risk.
  • Achieving better population-wide BP control is crucial for enhanced cardiovascular protection.
  • Future research should focus on addressing unmet goals to further improve patient outcomes.
Abstract

Related Concept Videos

Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...